SEC Form 4 · accession 0001209191-16-090631
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 8, 2016 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2016 | M | 12,000 | $0.87 | A | 64,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.47 | Jan 6, 2016 | A | 300,000 | A | — | Jan 5, 2026 | Common Stock | 300,000 | 300,000 | D |
| Employee Stock Option (right to buy)F2 | $0.87 | Jan 6, 2016 | M | 12,000 | A | — | Sep 10, 2019 | Common Stock | 12,000 | 45,323 | D |
Explanation of responses
- F1Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
- F2Fully vested.